BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6607027)

  • 1. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Ambrosino D; Halsey N; Goldmann DA; Mather FJ; Russell R; Kamon J; Murray M; Band JD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):658-62. PubMed ID: 6607027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b.
    Glode MP; Daum RS; Halsey NA; Johansen TL; Goldmann DA; Ambrosino D; Boies E; Granoff DM
    Rev Infect Dis; 1983; 5 Suppl 3():S549-55. PubMed ID: 6605565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Goldmann DA; Halsey N; Ambrosino D; Welborn C; Mather FJ; Willard JE; Sullivan B; Murray M; Johansen T
    J Pediatr; 1981 Mar; 98(3):485-91. PubMed ID: 7009819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections.
    Jadavji T; Cheung R; Bannatyne RM; Prober CG
    CMAJ; 1986 Aug; 135(4):328-31. PubMed ID: 3524784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.
    Gilbert GL; MacInnes SJ; Guise IA
    BMJ; 1991 Jun; 302(6790):1432-5. PubMed ID: 2070109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B.
    Green M; Li KI; Wald ER; Guerra N; Byers C
    Antimicrob Agents Chemother; 1992 Mar; 36(3):545-7. PubMed ID: 1622163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin.
    Yogev R; Melick C; Kabat K
    Pediatrics; 1981 Mar; 67(3):430-3. PubMed ID: 6972517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care.
    Li KI; Dashefsky B; Wald ER
    Pediatrics; 1986 Jul; 78(1):15-20. PubMed ID: 3487771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin prophylaxis v placebo for household contacts of children with Hemophilus influenzae type b disease.
    Murphy TV; Chrane DF; McCracken GH; Nelson JD
    Am J Dis Child; 1983 Jul; 137(7):627-32. PubMed ID: 6602542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin.
    Granoff DM; Gilsdorf J; Gessert C; Basden M
    Pediatrics; 1979 Mar; 63(3):397-401. PubMed ID: 312483
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro development of rifampin resistance in clinical isolates of Haemophilus influenzae type b.
    Yogev R; Melick C; Glogowski W
    Antimicrob Agents Chemother; 1982 Mar; 21(3):387-9. PubMed ID: 6980621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin prophylaxis against H. flu type b spread - is it valid?
    Daum RS; Glode MP
    Hosp Pract (Off Ed); 1982 Nov; 17(11):124A-C, 124K-L, 124N-P. PubMed ID: 6813223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampin for eradicating carriage of multiply resistant Haemophilus influenzae b.
    Campos J; Garcia-Tornel S; Roca J; Iriondo M
    Pediatr Infect Dis J; 1987 Aug; 6(8):719-21. PubMed ID: 3499591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease.
    Cox F; Trincher R; Rissing JP; Patton M; McCracken GH; Granoff DM
    JAMA; 1981 Mar; 245(10):1043-5. PubMed ID: 6970272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease.
    Gessert C; Granoff DM; Gilsdorf J
    Pediatrics; 1980 Jul; 66(1):1-4. PubMed ID: 6967580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts.
    Campos J; Garcia-Tornel S; Sanfeliu I
    Antimicrob Agents Chemother; 1984 Jun; 25(6):706-9. PubMed ID: 6611134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.